POSC18 The Real-World Clinical Effectiveness of GLP-1 Receptor Agonist Liraglutide Among Patients with Type 2 Diabetes in China: Based on Existing Healthcare Data
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.164
https://www.valueinhealthjournal.com/article/S1098-3015(21)01959-8/fulltext
Title :
POSC18 The Real-World Clinical Effectiveness of GLP-1 Receptor Agonist Liraglutide Among Patients with Type 2 Diabetes in China: Based on Existing Healthcare Data
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01959-8&doi=10.1016/j.jval.2021.11.164
First page :
Section Title :
Open access? :
No
Section Order :
10930